Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Major breakthrough in TB diagnosis
DNA
Scientists used genome techonology to isolate different strains of TB.
Scientists use genome sequencing to isolate strains of TB

Researchers in the UK have made a world-first breakthrough in the diagnosis of tuberculosis (TB).

According to BBC News, scientists at the Universities of Oxford and Birmingham have managed to isolate different strains of the disease using genome sequencing.

This means that patients will receive a diagnosis much faster, instead of waiting months for treatment.

Health secretary Jeremy Hunt said that the breakthrough "will save lives".

While incidents of TB in the UK have fallen in recent years, there are still some 6,000 cases reported each year. 

The illness is associated with health inequality, affecting people in deprived communities seven times more than people in the least deprived areas.

Scientists say they can identify the DNA strains in different samples in less than a week. As well as allowing patients to begin recovery sooner, this will also reduce the chance of infection spreading.

“We’re able to provide information on the species of organism and the drugs to which it may be resistant if it’s TB,” explained consultant microbiologist Dr Grace Smith.

This is the first time anyone in the world has applied genome technology on such a large scale, according to Public Health England.

The announcement comes as a new study shows that efforts to control the disease could be severely hampered by the rise in drug-resistant bacteria.

Published in The Lancet, the study found that one in five global cases of the disease is now resistant to at least one major treatment drug.

Become a member or log in to add this story to your CPD history

RUMA CA&E extends survey deadline

News Story 1
 RUMA CA&E has extended the deadline for its online survey into vaccine availability.

Vets, SQPs, retailers and wholesalers will now have until Friday, 26 September at 5pm to submit their response.

The survey aims to further understanding into the vaccine supply challenges faced by the sector. It will also consider the short and long term impacts of disruption issues.

Insights are anonymous, and will be shared with industry stakeholders and government bodies.

The survey can be accessed here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com